Updated: Jul 16, 2021
Historic moment for the UK’s medical sector as it receives its first ever import of the South African grown flower.
The South African cannabis manufacturer MedCan, has made history after being responsible for the first import of the high-THC cannabis flower to the UK this past week. THC is the main psychoactive compound of cannabis that causes “high” sensations. However, the compound also has an array of health benefits including chronic pain relief and is also believed to help lessen tremors in patients with Parkinson’s disease. MedCan’s first product called Isando, grown and produced in Johannesburg, will be made available to UK patients through Rokshaw Laboratories. MedCan, which began growing its cannabis in 2020, is one of the only GMP certified and fully licensed indoor cannabis cultivation facilities in SA. The cannabis maker collaborated with Maple Tree Consultancy and Rokshaw Laboratories to bring the breakthrough to fruition.
“We are immensely proud that our product has made its way to the United Kingdom and we intend to continue producing medical cannabis flowers that meet the highest international standards. Without the continued support of the South African Health Products Regulatory Authority as industry enablers, this process would not have been possible”, said MedCan’s Founder and Responsible Pharmacist, Dumani Dlamini. According to Data Breach Market Research, the global medical cannabis market is expected to grow at a CAGR of 25.16% over the next seven years, thus reaching over $67 billion by 2028. With a population of nearly 70 million, the UK is also seen to carry significant potential as a market and has recently amended its import requirements to ensure quicker access to cannabis-based medicines for the country’s citizens.